UnitedHealth Group Inc. 2008 10-K Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2008. UnitedHealth Group is a diversified health and well-being company serving more than 70 million Americans. The company operates through four reporting segments: Health Care Services (UnitedHealthcare, Ovations, AmeriChoice), OptumHealth, Ingenix, and Prescription Solutions. The reporting period was significantly impacted by the global financial crisis, a recessionary economic environment, and ongoing regulatory scrutiny regarding historical stock option practices.
Key Financial Metrics
| Metric | 2008 | 2007 | Change |
|---|---|---|---|
| Total Revenues | $81.2 billion | $75.4 billion | +8% |
| Net Earnings | $3.0 billion | $4.7 billion | -36% |
| Diluted EPS | $2.40 | $3.42 | -30% |
| Operating Margin | 6.5% | 10.4% | -3.9 pts |
| Medical Cost Ratio | 82.0% | 80.6% | +1.4 pts |
| Operating Cash Flow | $4.2 billion | $5.9 billion | -28% |
| Total Debt (CP + Long-Term) | $12.8 billion | $11.0 billion | +16% |
| Cash & Investments | $21.6 billion | $22.3 billion | -3% |
Material Changes vs. Prior Period
- Profitability Decline: Net earnings dropped 36% primarily due to a $1.7 billion decrease in earnings from operations. This was driven by higher medical costs outpacing premium rate increases in commercial and senior markets, and significant one-time charges.
- One-Time Charges: Operating costs included $882 million for proposed settlements of class action lawsuits related to historical stock option practices and $350 million for a settlement regarding out-of-network medical service reimbursements.
- Acquisitions: The company completed three major acquisitions in 2008: Sierra Health Services ($2.6 billion), Unison Health Plans ($930 million), and Fiserv Health ($740 million). These contributed to revenue growth but added to operating costs.
- Investment Income: Investment and other income decreased 33% to $771 million due to lower interest rates and increased other-than-temporary impairment charges related to financial market disruptions.
- Enrollment Trends: Commercial risk-based enrollment declined 4% due to competitive pricing, while Medicaid enrollment grew 47% due to economic conditions and acquisitions.
Guidance, Outlook, Risks, and Unusual Items
- Economic Outlook: Management expects the recession to slow revenue growth and impact operating profitability. Higher unemployment may reduce employer group enrollments but increase Medicaid participation.
- Regulatory Risks: Significant uncertainty exists regarding proposed federal health care reforms, particularly potential reductions in Medicare Advantage payments. The company is also subject to ongoing audits by CMS regarding risk adjustment coding.
- Legal Contingencies: The company is involved in various litigation matters, including shareholder derivative suits and securities class actions related to historical stock option practices. A settlement of $895 million was reached for the securities class action, and $17 million for an ERISA 401(k) lawsuit.
- Investment Portfolio: The portfolio held gross unrealized losses of $349 million as of year-end. Management does not currently consider these losses other-than-temporary but notes that further market deterioration could require impairment charges.
- Liquidity: Despite the economic downturn, the company maintains a strong liquidity position with $21.6 billion in cash and investments and access to $3.25 billion in committed credit facilities.
Key Facts for Investor Verification
- Medical Cost Development: Verify the sensitivity of future earnings to medical cost trends; a 1% increase in medical costs without a revenue offset could reduce annual net earnings by approximately $200 million.
- Settlement Finality: Confirm the final court approval status of the $895 million securities class action settlement and the $350 million out-of-network reimbursement settlement.
- Medicare Advantage Exposure: Monitor legislative developments regarding Medicare Advantage payment rates, as reductions could materially impact the Ovations segment and overall margins.
- Stock Option Litigation: Track the resolution of remaining regulatory inquiries (SEC, IRS, State Attorneys General) regarding historical stock option practices to assess potential for additional charges.
- Investment Impairments: Review quarterly updates on the investment portfolio for any new other-than-temporary impairment charges resulting from continued market volatility.